TNFRSF8 and Bone marrow hypocellularity: Our findings suggested that CD30 as a cell surface marker that transiently expressed on activated T cells, might be associated with T cell-mediated bone marrow failure in AA, which could facilitate our understanding of AA pathogenesis to identify new therapeutic targets.